Fig. 4From: A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov modelCost- effectiveness acceptability curve for fixed dose combination therapy versus dutasterideBack to article page